452 related articles for article (PubMed ID: 20804120)
1. Heme as trigger and target for trioxane-containing antimalarial drugs.
Meunier B; Robert A
Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
[TBL] [Abstract][Full Text] [Related]
2. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
3. Heme alkylation by artesunic acid and trioxaquine DU1301, two antimalarial trioxanes.
Laurent SA; Loup C; Mourgues S; Robert A; Meunier B
Chembiochem; 2005 Apr; 6(4):653-8. PubMed ID: 15744769
[TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry perspectives of trioxanes and tetraoxanes.
Kumar N; Sharma M; Rawat DS
Curr Med Chem; 2011; 18(25):3889-928. PubMed ID: 21824099
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent.
Hartwig CL; Rosenthal AS; D'Angelo J; Griffin CE; Posner GH; Cooper RA
Biochem Pharmacol; 2009 Feb; 77(3):322-36. PubMed ID: 19022224
[TBL] [Abstract][Full Text] [Related]
6. Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action.
Jefford CW
Curr Med Chem; 2001 Dec; 8(15):1803-26. PubMed ID: 11772352
[TBL] [Abstract][Full Text] [Related]
7. Alkylation of human hemoglobin A0 by the antimalarial drug artemisinin.
Selmeczi K; Robert A; Claparols C; Meunier B
FEBS Lett; 2004 Jan; 556(1-3):245-8. PubMed ID: 14706857
[TBL] [Abstract][Full Text] [Related]
8. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
9. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
Rudrapal M; Chetia D
Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
[TBL] [Abstract][Full Text] [Related]
10. Stochastic Protein Alkylation by Antimalarial Peroxides.
Jourdan J; Walz A; Matile H; Schmidt A; Wu J; Wang X; Dong Y; Vennerstrom JL; Schmidt RS; Wittlin S; Mäser P
ACS Infect Dis; 2019 Dec; 5(12):2067-2075. PubMed ID: 31626733
[TBL] [Abstract][Full Text] [Related]
11. Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials.
Creek DJ; Charman WN; Chiu FC; Prankerd RJ; Dong Y; Vennerstrom JL; Charman SA
Antimicrob Agents Chemother; 2008 Apr; 52(4):1291-6. PubMed ID: 18268087
[TBL] [Abstract][Full Text] [Related]
12. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the reactivity of antimalarial 1,2,4,5-tetraoxanes with 1,2,4-trioxolanes in the presence of ferrous iron salts, heme, and ferrous iron salts/phosphatidylcholine.
Bousejra-El Garah F; Wong MH; Amewu RK; Muangnoicharoen S; Maggs JL; Stigliani JL; Park BK; Chadwick J; Ward SA; O'Neill PM
J Med Chem; 2011 Oct; 54(19):6443-55. PubMed ID: 21888440
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin Derivatives and Synthetic Trioxane Trigger Apoptotic Cell Death in Asexual Stages of
Gunjan S; Sharma T; Yadav K; Chauhan BS; Singh SK; Siddiqi MI; Tripathi R
Front Cell Infect Microbiol; 2018; 8():256. PubMed ID: 30094226
[TBL] [Abstract][Full Text] [Related]
15. Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action.
Haynes RK; Chan WC; Wong HN; Li KY; Wu WK; Fan KM; Sung HH; Williams ID; Prosperi D; Melato S; Coghi P; Monti D
ChemMedChem; 2010 Aug; 5(8):1282-99. PubMed ID: 20629071
[TBL] [Abstract][Full Text] [Related]
16. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
17. An overview on the antimalarial activity of 1,2,4-trioxanes, 1,2,4-trioxolanes and 1,2,4,5-tetraoxanes.
Shukla M; Rathi K; Hassam M; Yadav DK; Karnatak M; Rawat V; Verma VP
Med Res Rev; 2024 Jan; 44(1):66-137. PubMed ID: 37222435
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs.
Mott BT; Tripathi A; Siegler MA; Moore CD; Sullivan DJ; Posner GH
J Med Chem; 2013 Mar; 56(6):2630-41. PubMed ID: 23425037
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Plasmodium yoelii nigeriensis susceptibility to artemisinin and alkylation of heme by the drug.
Robert A; Claparols C; Witkowski B; Benoit-Vical F
Antimicrob Agents Chemother; 2013 Aug; 57(8):3998-4000. PubMed ID: 23752508
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the synthesis and antimalarial activity of 1,2,4-trioxanes.
Rathi K; Shukla M; Hassam M; Shrivastava R; Rawat V; Prakash Verma V
Bioorg Chem; 2024 Feb; 143():107043. PubMed ID: 38134523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
